New York, NY

New York, New York 10029

0 studies enrolling now · 4 studies all time

What they study most

Comorbidity, Diabetic Macular Edema (DME), Myocardial Infarction, Neurotrophic Keratopathy, Smoking

Studies at this site

• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy — Completed
• Web-Enhanced Guideline Implementation for Post MI CBOC Patients — Completed
• TeleQuit Smoking Cessation Program — Completed